C W Menke-van der Houven van Oordt Selected Research

zirconium-89-trastuzumab

4/2016

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C W Menke-van der Houven van Oordt Research Topics

Disease

4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 08/2014
3	Neoplasms (Cancer) 01/2020 - 04/2016
2	Breast Neoplasms (Breast Cancer) 04/2016 - 01/2008
1	Neoplasm Metastasis (Metastasis) 08/2014
1	Carcinogenesis 08/2014
1	Heart Failure 01/2008
1	Cardiomyopathies (Cardiomyopathy) 01/2008
1	Cardiotoxicity 01/2008
1	Pheochromocytoma 01/2007

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2014
1	Cetuximab (Erbitux)FDA Link 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Monoclonal AntibodiesIBA 06/2017
1	zirconium-89-trastuzumabIBA 04/2016
1	Ado-Trastuzumab EmtansineIBA 04/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2016
1	ErbB Receptors (EGF Receptor)IBA 08/2014
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2014
1	human ERBB2 proteinIBA 01/2008
1	AnthracyclinesIBA 01/2008
1	Trastuzumab (Herceptin)FDA Link 01/2008
1	CatecholaminesIBA 01/2007

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2008
1	Therapeutics 01/2008
1	Adrenalectomy 01/2007